Inherent Biosciences, Inc.
PrivateLast Round
Accelerator
Jun 2, 2025
Total Funding Raised
$4.01M
Company Overview
Inherent Biosciences, Inc. is a biotechnology company that develops epigenetic medicine platforms and diagnostic tools for complex diseases, with a primary focus on reproductive health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inherent Biosciences, Inc. Comparables
Compare Inherent Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomic Prediction | 74% | |
| Fellow | 70% | |
| Posterity Health | 70% | |
Inherent Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 2, 2025 | ||||
| VC Round | Dec 12, 2023 | ||||
| Grant | Aug 17, 2023 | ||||
| Grant | May 31, 2023 | ||||
| Series A | Sep 7, 2022 | ||||
Grant | Apr 1, 2022 |
Key People
Founding team and executive leadership
Inherent Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Portfolia | Series A |
| Utah Innovation Fund | VC Round |
| Propel Bio Partners | Series A |
| HealthTech Investors | Accelerator |
| Rhythm Venture Capital | Seed |
| Park City Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2021
Led by National Science Foundation with participation from Kickstart.
Inherent Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inherent Biosciences, Inc.'s valuation, stock price, and market status.